SAN FRANCISCO, CA USA (UroToday.com) - Presented by Evan Y. Yu, Fred Saad, Anil Londhe, Neal D. Shore, Hendrik Van Poppel, Dana E. Rathkopf, Matthew R. Smith, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul Mainwaring, John D. Hainsworth, Tomasz M. Beer, Scott North, Eric J. Small, Howard I. Scher, Thomas W. Griffin, Margaret K. Yu, and Charles J. Ryan at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
Fred Hutchinson Cancer Research Center, Seattle, WA; University of Montréal, Montréal, QC, Canada; Janssen Research & Development, LLC, Raritan, NJ; Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC; University Hospital Leuven, Leuven, Belgium; Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harvard Medical School and Massachusetts General Hospital, Boston, MA; MD Anderson Cancer Center, Houston, TX; University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia; Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Radboud University Medical Centre, Nijmegen, The Netherlands; Hematology and Oncology Clinics of Australia, Brisbane, Australia; Sarah Cannon Research Institute, Nashville, TN; Oregon Health & Science University Knight Cancer Institute, Portland, OR; Cross Cancer Institute, Edmonton, AB, Canada; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Janssen Research & Development, Los Angeles, CA
